Literature DB >> 20924610

The hypnozoite concept, with particular reference to malaria.

Miles B Markus1.   

Abstract

In 1978, the nature of the hypnozoite was discussed in an article that appeared in a relatively obscure journal, which is also where the term was adopted for Plasmodium (a little-known fact). As a result, that commentary on the use of the word "hypnozoite" has been almost completely overlooked. Although the publication is now more than three decades old, the analysis remains valid today. It is explained in the present paper that like "merozoite" and "sporozoite", the name "hypnozoite" is applicable not only to a latent stage in the life cycle of Plasmodium but to some apparently dormant forms of other kinds of apicomplexan parasites as well. Merozoites of different genera of parasitic protozoa are not necessarily the same biologically and/or otherwise. Similarly, although the hypnozoite concept relates primarily to pre-merozoite stages, some atypical post-divisional apicomplexan forms might also be hypnozoites. Examples are likewise given of latent organisms that, in contrast, are clearly not hypnozoites, such as dormant merozoites in malaria infections. Lastly, the plasmodial hypnozoite is placed in context in relation to the relatively unfamiliar (nomenclaturally) malarial bradysporozoite, chronozoite, dormozoite, merophore, merosome and x body. This paper is based on a presentation by the author, as a Life Member of the American Society of Tropical Medicine and Hygiene, to its 59th Annual Meeting in Atlanta, Georgia, USA, 3-7 November 2010.

Entities:  

Mesh:

Year:  2010        PMID: 20924610     DOI: 10.1007/s00436-010-2072-y

Source DB:  PubMed          Journal:  Parasitol Res        ISSN: 0932-0113            Impact factor:   2.289


  62 in total

1.  Lymphokine-induced inhibition of growth of Eimeria bovis and Eimeria papillata (Apicomplexa) in cultured bovine monocytes.

Authors:  C A Speer; D W Reduker; D E Burgess; W M Whitmire; G A Splitter
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

2.  Recurrent parasitemias and population dynamics of Plasmodium vivax polymorphisms in rural Amazonia.

Authors:  Pamela Orjuela-Sánchez; Natal Santos da Silva; Mônica da Silva-Nunes; Marcelo Urbano Ferreira
Journal:  Am J Trop Med Hyg       Date:  2009-12       Impact factor: 2.345

3.  [Effect of environmental temperature, cryopreservation and aging on Plasmodium vivax sporozoites developing into exoerythrocytic stages].

Authors:  D Liu; S Lou; H Shu; R Fu; B Ye
Journal:  Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi       Date:  1995

4.  About the hypnozoites of the vivax-like group of Plasmodia.

Authors:  A Corradetti
Journal:  Trans R Soc Trop Med Hyg       Date:  1985       Impact factor: 2.184

5.  Observations on early and late post-sporozoite tissue stages in primate malaria. II. The hypnozoite of Plasmodium cynomolgi bastianellii from 3 to 105 days after infection, and detection of 36- to 40-hour pre-erythrocytic forms.

Authors:  W A Krotoski; R S Bray; P C Garnham; R W Gwadz; R Killick-Kendrick; C C Draper; G A Targett; D M Krotoski; M W Guy; L C Koontz; F B Cogswell
Journal:  Am J Trop Med Hyg       Date:  1982-03       Impact factor: 2.345

6.  Observations on early and late post-sporozoite tissue stages in primate malaria. I. Discovery of a new latent form of Plasmodium cynomolgi (the hypnozoite), and failure to detect hepatic forms within the first 24 hours after infection.

Authors:  W A Krotoski; P C Garnham; R S Bray; D M Krotoski; R Killick-Kendrick; C C Draper; G A Targett; M W Guy
Journal:  Am J Trop Med Hyg       Date:  1982-01       Impact factor: 2.345

7.  Two malaria parasites (Apicomplexa: Plasmodiidae) of the Australian skink Egernia stokesii.

Authors:  S R Telford; J Stein
Journal:  J Parasitol       Date:  2000-04       Impact factor: 1.276

8.  Relapses of Plasmodium vivax infection usually result from activation of heterologous hypnozoites.

Authors:  Mallika Imwong; Georges Snounou; Sasithon Pukrittayakamee; Naowarat Tanomsing; Jung Ryong Kim; Amitab Nandy; Jean-Paul Guthmann; Francois Nosten; Jane Carlton; Sornchai Looareesuwan; Shalini Nair; Daniel Sudimack; Nicholas P J Day; Timothy J C Anderson; Nicholas J White
Journal:  J Infect Dis       Date:  2007-02-26       Impact factor: 5.226

9.  P. falciparum malaria recrudescence in a cancer patient.

Authors:  E Foca; R Zulli; F Buelli; M De Vecchi; A Regazzoli; F Castelli
Journal:  Infez Med       Date:  2009-03

10.  Ultrastructure of in vivo-produced caryocysts containing the coccidian Caryospora bigenetica (Apicomplexa: Eimeriidae).

Authors:  C A Sundermann; D S Lindsay
Journal:  J Protozool       Date:  1989 Jan-Feb
View more
  17 in total

Review 1.  What is the evidence for the existence of Plasmodium ovale hypnozoites?

Authors:  Joachim Richter; Gabriele Franken; Heinz Mehlhorn; Alfons Labisch; Dieter Häussinger
Journal:  Parasitol Res       Date:  2010-10-05       Impact factor: 2.289

2.  The painstaking discovery of the hidden face of the human plasmodia.

Authors:  Jean-François Pays
Journal:  Parasitol Res       Date:  2012-05-18       Impact factor: 2.289

Review 3.  Looking under the skin: the first steps in malarial infection and immunity.

Authors:  Robert Ménard; Joana Tavares; Ian Cockburn; Miles Markus; Fidel Zavala; Rogerio Amino
Journal:  Nat Rev Microbiol       Date:  2013-10       Impact factor: 60.633

Review 4.  Translational control in Plasmodium and toxoplasma parasites.

Authors:  Min Zhang; Bradley R Joyce; William J Sullivan; Victor Nussenzweig
Journal:  Eukaryot Cell       Date:  2012-12-14

5.  Avian haemosporidian detection across source materials: prevalence and genetic diversity.

Authors:  Johanna A Harvey; Gary Voelker
Journal:  Parasitol Res       Date:  2017-10-23       Impact factor: 2.289

6.  Novel potent metallocenes against liver stage malaria.

Authors:  Joana Matos; Filipa P da Cruz; Élia Cabrita; Jiri Gut; Fátima Nogueira; Virgílio E do Rosário; Rui Moreira; Philip J Rosenthal; Miguel Prudêncio; Paula Gomes
Journal:  Antimicrob Agents Chemother       Date:  2011-12-12       Impact factor: 5.191

7.  Why do Plasmodium malariae infections sometimes occur in spite of previous antimalarial medication?

Authors:  Gabriele Franken; Irmela Müller-Stöver; Martha C Holtfreter; Susanne Walter; Heinz Mehlhorn; Alfons Labisch; Dieter Häussinger; Joachim Richter
Journal:  Parasitol Res       Date:  2012-02-18       Impact factor: 2.289

8.  High prevalence and genetic diversity of Plasmodium malariae and no evidence of Plasmodium knowlesi in Bangladesh.

Authors:  Hans-Peter Fuehrer; Paul Swoboda; Josef Harl; Peter Starzengruber; Verena Elisabeth Habler; Ingrid Bloeschl; Rashidul Haque; Julia Matt; Wasif Ali Khan; Harald Noedl
Journal:  Parasitol Res       Date:  2014-02-28       Impact factor: 2.289

Review 9.  Clinical implications of a gradual dormancy concept in malaria.

Authors:  Joachim Richter; Gabriele Franken; Martha C Holtfreter; Susanne Walter; Alfons Labisch; Heinz Mehlhorn
Journal:  Parasitol Res       Date:  2016-04-15       Impact factor: 2.289

10.  Stem cell therapy for the treatment of parasitic infections: is it far away?

Authors:  Yan Zhang; Jing-Yi Mi; Yong-Jun Rui; Yong-Liang Xu; Wei Wang
Journal:  Parasitol Res       Date:  2013-11-26       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.